Medtronic Acquires Diabeter As Part Of Integrated Health Strategy
This article was originally published in The Gray Sheet
Netherlands-based Diabeter is one of Europe’s largest independent diabetes specialist care centers. It will enhance Medtronic’s ongoing strategy to become a complete healthcare “solutions” company.
You may also be interested in...
The company’s leadership team is “determined to transform Medtronic from being a primarily device provider today into the premier global medical technology solutions partner of tomorrow,” CEO Omar Ishrak said.
A new entrant into the top five global generics and biosimilars companies shows how transformations for some of the leading off-patent players are reshaping the industry landscape, with more major changes in the pipeline. We examine the 10 leaders of the pack in the first instalment of this year’s Generics Bulletin Top 50.
Syngene’s COO, Mahesh Bhalgat, tells Scrip the firm is better placed than some peers to serve clients for biologics-based advanced therapies and address the cost element for new modalities like mRNA. He also outlines the research, development and manufacturing services company's capabilities in oligonucleotide-based therapeutics, an area that's seeing growing interest.